Evidence map›Paper›PMID 32117204›Full record

ArticleFrontiers in immunology2019

Immunogenicity of Potential CD4

Rafael de Freitas E Silva, Beatriz Coutinho de Oliveira, Ailton Alvaro da Silva, Maria Carolina Accioly Brelaz de Castro, Luiz Felipe Gomes Rebello Ferreira, Marcelo Zaldini Hernandes, Maria Edileuza Felinto de Brito, Osvaldo Pompílio de-Melo-Neto, Antônio Mauro Rezende, Valéria Rêgo Alves Pereira

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Evaluation of the Antigenic Potential of Epitopes Derived FromBioinformatics and biology insights · 2025
    Article
  3. Article
  4. Article
  5. Revisiting the Principles of Designing a Vaccine.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Rafael de Freitas E SilvaDepartment of Natural Sciences, Universidade de Pernambuco, Garanhuns, Brazil.
Beatriz Coutinho de OliveiraDepartment of Immunology, Fundação Oswaldo Cruz, Recife, Brazil.
Ailton Alvaro da SilvaDepartment of Immunology, Fundação Oswaldo Cruz, Recife, Brazil.
Maria Carolina Accioly Brelaz de CastroDepartment of Immunology, Fundação Oswaldo Cruz, Recife, Brazil.
Luiz Felipe Gomes Rebello FerreiraDepartment of Pharmaceutical Sciences, Universidade Federal de Pernambuco, Recife, Brazil.
Marcelo Zaldini HernandesDepartment of Pharmaceutical Sciences, Universidade Federal de Pernambuco, Recife, Brazil.
Maria Edileuza Felinto de BritoDepartment of Immunology, Fundação Oswaldo Cruz, Recife, Brazil.
Osvaldo Pompílio de-Melo-NetoDepartment of Microbiology, Fundação Oswaldo Cruz, Recife, Brazil.
Antônio Mauro RezendeDepartment of Microbiology, Fundação Oswaldo Cruz, Recife, Brazil.
Valéria Rêgo Alves PereiraDepartment of Immunology, Fundação Oswaldo Cruz, Recife, Brazil.
Fundação Oswaldo Cruz · BRUniversidade Federal de Pernambuco · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antigens, ProtozoanCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesEpitopes, T-LymphocyteHumansLeishmania braziliensisLeishmaniasis, CutaneousLymphocyte ActivationProteomeAntigens, ProtozoanEpitopes, T-LymphocyteProteomeCD4+ CD8+ T cell epitopescutaneous leishmaniasisimmunogenicityLeishmania (Viannia) braziliensisneglected diseases

Identifiers

PMID32117204
PMCPMC7033680
OpenAlexW3006475235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.